Serum response factor regulates smooth muscle contractility via myotonic dystrophy protein kinases and L-type calcium channels by Moon Young Lee (749843)

“…Deficiency of SRF in SMC of <i>Srf</i> knockout (KO) mice led to reduction of SRF-dependent DMPK, which down-regulated the expression of CACNA1C. Reduction of CACNA1C in KO SMC not only decreased intracellular Ca²⁺ spikes but also disrupted their coupling between cells resulting in decreased contractility. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Data Sheet 5_The March and April 2023 ionospheric storms over Europe.pdf by Zbyšek Mošna (19743394)

“…We investigate the ionospheric response in the middle-latitudinal European region utilizing ionospheric vertical sounding at five European stations: Juliusruh, Dourbes, Pruhonice, Sopron, and a reference station, San Vito. …”

Table_5_Cathepsins and Parkinson’s disease: insights from Mendelian randomization analyses.CSV by Aishanjiang Yusufujiang (12895259)

Alumina-Supported NiMo Hydrotreating CatalystsAspects of 3D Structure, Synthesis, and Activity by Mengyan Li (1858759)

Alumina-Supported NiMo Hydrotreating CatalystsAspects of 3D Structure, Synthesis, and Activity by Mengyan Li (1858759)

Alumina-Supported NiMo Hydrotreating CatalystsAspects of 3D Structure, Synthesis, and Activity by Mengyan Li (1858759)

Alumina-Supported NiMo Hydrotreating CatalystsAspects of 3D Structure, Synthesis, and Activity by Mengyan Li (1858759)

Mangifera indica L. kernel ethanol extract inhibits cell viability and proliferation with induction of cell cycle arrest and apoptosis in lung cancer cells by Alshwyeh, Hussah Abdullah

“…Furthermore, the extract exhibited higher toxicity towards NCI-H292 cells, followed by A549 and normal MRC-5 cells in decreasing order of potency. …”
Get full text
Get full text
Get full text

Table_5_Gamma Band Oscillations Reflect Sensory and Affective Dimensions of Pain.docx by Yuanyuan Lyu (5278652)

Table5_Circadian Pharmacological Effects of Paeoniflorin on Mice With Urticaria-like Lesions.xlsx by Li Peng (83452)

Table5_Circadian Pharmacological Effects of Paeoniflorin on Mice With Urticaria-like Lesions.xlsx by Li Peng (83452)

The effect of kinetics V_S of NaP on PIC patterns and firing types. by Yi Cheng (317041)

“…<p><b>A.</b> The steady-state of gating activation (<i>m</i>_NaP) curve of NaP was established when V_S was set to 3 (green), 5 (black, control), and 7 mV (orange), respectively. …”

Image_5_Depletion of Oxygen in the Bothnian Sea Since the Mid-1950s.png by Igor V. Polyakov (1295811)